Buchumschlag

Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Rithin Nedumannil, Tal Karmi, Piers Blombery, Jeff Szer, David S. Ritchie, Lynette C. Y. Chee
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Haematology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
von: Francesca Perutelli, et al.
Veröffentlicht: (2025)

Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
von: Xiaolu Zhu, et al.
Veröffentlicht: (2025)

Isolated testicular second‐relapsed T‐lymphoblastic lymphoma after allogeneic stem cell transplantation: Therapeutic implication from sequential molecular genetic analysis
von: Kohei Fukuoka, et al.
Veröffentlicht: (2024)

Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia
von: Francesca A. M. Kinsella, et al.
Veröffentlicht: (2024)

Monitoring the KMT2A gene post‐chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation
von: Jing Liu, et al.
Veröffentlicht: (2025)

Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis
von: Jacopo Mariotti, et al.
Veröffentlicht: (2025)

Prior status of graft‐versus‐host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation
von: Claudia Mae Velasco, et al.
Veröffentlicht: (2025)

Risk factors and survival analysis of human leukocyte antigen loss in relapsed acute myeloid leukaemia/myelodysplastic syndrome patients after allogeneic haematopoietic stem cell transplantation
von: Tingting Zhang, et al.
Veröffentlicht: (2024)

Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation
von: Jin Wu, et al.
Veröffentlicht: (2024)

A pragmatic monitoring model for risk of non‐relapse mortality based on biomarkers in patients undergoing allogeneic haematopoietic stem‐cell transplantation
von: Yangliu Shao, et al.
Veröffentlicht: (2025)

Long‐term outcomes after allogeneic versus autologous haematopoietic stem cell transplantation for T‐lymphoblastic lymphoma
von: Qian Cheng, et al.
Veröffentlicht: (2026)

The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation
von: Xu‐Ying Pei, et al.
Veröffentlicht: (2025)

Enterococcus proliferates via the phosphotransferase system in the disrupted gut microbiota after allogeneic haematopoietic stem cell transplantation
von: Akihisa Hino, et al.
Veröffentlicht: (2025)

Utility of transplant conditioning intensity score in allogeneic haematopoietic stem cell transplantation for genetic disorders
von: Koji Kawaguchi, et al.
Veröffentlicht: (2026)

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
von: Jennifer O'Sullivan, et al.
Veröffentlicht: (2024)

Interpretable machine learning model using peripheral blood for non‐invasive detection of moderate‐to‐severe myelofibrosis in JAK2 V617F ‐positive MPNs : A multicentre pilot proof‐of‐concept study
von: Zhuanghui Hao, et al.
Veröffentlicht: (2026)

Venetoclax plus hypomethylating agents as effective bridge therapy to allogeneic stem cell transplant in relapsed/refractory acute myeloid leukaemia: A subanalysis of the AVALON study
von: Elisabetta Petracci, et al.
Veröffentlicht: (2025)

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party
von: Nimrod Buchbinder, et al.
Veröffentlicht: (2025)

An unexpected cause of pancytopenia after allogeneic bone marrow transplant
von: Tristan Jordan, et al.
Veröffentlicht: (2026)

Avatrombopag for post‐transplant thrombocytopenia following allogeneic haematopoietic stem cell transplantation: A single‐centre retrospective study
von: Cristian Alberdi‐Lema, et al.
Veröffentlicht: (2026)

Precision immune‐guided management of cytomegalovirus ( CMV ) after allogeneic haematopoietic stem cell transplantation in the letermovir era: A pragmatic framework
von: Xinyi Jiang, et al.
Veröffentlicht: (2026)

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium
von: Flore Sicre de Fontbrune, et al.
Veröffentlicht: (2024)

Donor age and type in allogeneic haematopoietic stem cell transplantation: Strong effect in MDS , limited in AML
von: Dong Hyun Kim, et al.
Veröffentlicht: (2025)

Comprehensive risk stratification for adult T‐cell lymphoblastic lymphoma undergoing allogeneic haematopoietic stem cell transplantation
von: Fangfang Yu, et al.
Veröffentlicht: (2025)

A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy
von: Xing‐yu Cao, et al.
Veröffentlicht: (2024)

Prognostic mutations identified by whole‐exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation
von: Hong Wang, et al.
Veröffentlicht: (2024)

HAT ‐ PCR is non‐inferior to NGS when quantifying measurable residual disease for myeloma
von: Elizabeth Hughes, et al.
Veröffentlicht: (2026)

Contrasting impacts of pretransplant cytoreduction and post‐transplant maintenance on outcomes of allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes: Real‐world multicentre evidence
von: Yilin Chen, et al.
Veröffentlicht: (2026)

Clinical and genetic profiles and outcomes of allogeneic haematopoietic stem cell transplantation in secondary myelodysplastic syndrome following aplastic anaemia
von: Jia Li, et al.
Veröffentlicht: (2024)

Mixed chimerism post allogeneic stem cell transplant for Chediak–Higashi syndrome—Clues from morphology and blood banking
von: Sean McKeague, et al.
Veröffentlicht: (2024)

Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report
von: E. Laspa, et al.
Veröffentlicht: (2025)

Azacitidine combined with interferon‐α for pre‐emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study
von: Chongmei Huang, et al.
Veröffentlicht: (2024)

Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients
von: Takaaki Ono, et al.
Veröffentlicht: (2026)

Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
von: Yiling Ye, et al.
Veröffentlicht: (2025)

A randomized trial of ibrutinib and R‐GDP prior to stem cell transplant in relapsed diffuse large B‐cell lymphoma
von: John Kuruvilla, et al.
Veröffentlicht: (2024)

The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation
von: Hartmut Bertz, et al.
Veröffentlicht: (2025)

The impact of matched and mismatched donor–recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation
von: Ziwen Duan, et al.
Veröffentlicht: (2024)

Prevalence and impact of additional CHIP mutations in JAK2V617F‐positive ischaemic cerebrovascular patients
von: Marie Hvelplund Kristiansen, et al.
Veröffentlicht: (2025)

Clinical perspectives on post‐induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation
von: Kendra Sweet, et al.
Veröffentlicht: (2024)

Excellent outcomes in children after haematopoietic stem cell transplantation for hepatitis‐associated aplastic anaemia following liver transplantation
von: Satish Kumar Meena, et al.
Veröffentlicht: (2026)